David Garry, MD
Payments from drug & device makers
Across 42 payments — averaging $30.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$351
- TELA Bio, Inc.$228
- Johnson & Johnson$163
- Varian Medical Systems, Inc.$92
- Medtronic$75
- Acell, Inc.$60
- plus $327 from 14 others
What the payments were for
- Food & beverage$1,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 8 | $351 |
| TELA Bio, Inc. | 2 | $228 |
| Johnson & Johnson(2 entities) | 7 | $163 |
| Varian Medical Systems, Inc. | 1 | $92 |
| Medtronic | 2 | $75 |
| Acell, Inc. | 5 | $60 |
| Aroa Biosurgery Incorporated | 2 | $47 |
| Kerecis Limited | 2 | $43 |
| Shire North American Group Inc | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $34 |
| Teleflex LLC | 1 | $21 |
| Innocoll Pharmaceuticals Limited | 1 | $21 |
| TEI Biosciences Inc | 1 | $20 |
| Acera Surgical, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| Intuitive Surgical | 1 | $15 |
| Covidien LP | 1 | $14 |
| Edwards Lifesciences | 1 | $14 |
| KCI USA, Inc. | 1 | $12 |
| Polynovo North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,296 in reported general payments places this provider in the 45th percentile of 202 surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $95 |
Paid to pharmacies, not to this prescriber.
Other surgery in Provo
- R RasmussenProvo$79K
- Bruce HillProvo$23K
- Jennifer TittensorProvo$22K
- John WennergrenProvo$21K
- Gregory PeirceProvo$11K
- Sarah MajercikMurray$914K
- Ivan Zendejas RuizMurray$361K
- Jorge de Amorim FilhoSalt Lake City$344K
- Tawnya BowlesMurray$307K
- Daniel CottamSalt Lake City$294K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.